Evidence map›Paper›PMID 26726292›Full record

ArticleEuropean journal of organic chemistry2015

The Industrial Age of Biocatalytic Transamination.

Michael Fuchs, Judith E Farnberger, Wolfgang Kroutil

Open access · bronzeAbstract read
In one paragraph

Article in European journal of organic chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
11.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 240 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Biocatalytic cascade to polysaccharide amination.Biotechnology for biofuels and bioproducts · 2024
    Article
  10. Article
  11. Article
  12. Shifting the pH Optima of (International journal of molecular sciences · 2022
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Engineering Novel (Applied and environmental microbiology · 2022
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Michael FuchsDepartment of Chemistry, Organic and Bioorganic Chemistry, University of Graz NAWI Graz Heinrichstrasse 28, 8010 Graz, Austria E-mail: wolfgang.kroutil@uni-graz.at http://biocatalysis.uni-graz.at.
Judith E FarnbergerAustrian Centre of Industrial Biotechnology (acib), c/o University of Graz Heinrichstrasse 28, 8010 Graz, Austria.
Wolfgang KroutilDepartment of Chemistry, Organic and Bioorganic Chemistry, University of Graz NAWI Graz Heinrichstrasse 28, 8010 Graz, Austria E-mail: wolfgang.kroutil@uni-graz.at http://biocatalysis.uni-graz.at.
University of Graz · AT

Funding

Austrian Science Fund FWF J 3466
6 · The paper itself

Abstract

During the last decade the use of ω-transaminases has been identified as a very powerful method for the preparation of optically pure amines from the corresponding ketones. Their immense potential for the preparation of chiral amines, together with their ease of use in combination with existing biocatalytic methods, have made these biocatalysts a competitor to any chemical methodology for (asymmetric) amination. An increasing number of examples, especially from industry, shows that this biocatalytic technology outmaneuvers existing chemical processes by its simple and flexible nature. In the last few years numerous publications and patents on synthetic routes, mainly to pharmaceuticals, involving ω-transaminases have been published. The review gives an overview of the application of ω-transaminases in organic synthesis with a focus on active pharmaceutical ingredients (APIs) and the developments during the last few years.

Indexed as

AminesAsymmetric synthesisBiocatalysisEnzyme catalysisTransamination

Identifiers

PMID26726292
PMCPMC4690199
OpenAlexW1926603859

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.